LianBio
LIANY- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001831283
No open-market purchases or sales by LianBio insiders were filed in the last 90 days; 1 institution reported holding it in 13F filings for Q2 2026, worth $1.00K in total; no superinvestor holds it.
Holders of 5% or more of LIANY
Holders whose latest Schedule 13D or 13G filing reports 5% or more of LianBio, largest stake first. The change is against the holder's previous filing.
No holder currently reports owning 5% or more of LianBio on Schedule 13D or 13G.
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
5 Schedule 13D and 13G filings on LianBio, newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| Feb 14, 2023 | Venrock Healthcare Capital Partners II, L.P. | 13G/AOld format | – | – | – | SEC |
| Nov 14, 2022 | Ra Capital Management, L.P. | 13G/AOld format | – | – | – | SEC |
| Nov 15, 2021 | Perceptive Advisors LLC | 13DOld format | – | New | – | SEC |
| Nov 15, 2021 | Ra Capital Management, L.P. | 13GOld format | – | New | – | SEC |
| Nov 10, 2021 | Venrock Healthcare Capital Partners II, L.P. | 13GOld format | – | New | – | SEC |
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell LianBio shares.
No Form 144 notices for LianBio are on file.